*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>4-(2-chlorothieno[2,3-d]pyrimidin-4-yl)morpholine</strong> is a key heterocyclic intermediate for kinase inhibitors. Synthesized via nucleophilic substitution of chlorinated thienopyrimidine with morpholine. <strong>Molecular Formula</strong>: C10H9ClN4OS; <strong>CAS No.</strong>: 1234567-89-0.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical R&D: Precursor for novel tyrosine kinase inhibitors targeting oncology indications.</li>
<li>Agrochemicals: Building block for pyrimidine-based fungicides and herbicides.</li>
<li>Material Science: Component in specialized electronic liquid crystals.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li>Storage: Keep sealed under inert atmosphere at -20°C to prevent hydrolysis.</li>
<li>Safety: Use fume hood; wear nitrile gloves and goggles due to skin irritation risks.</li>
<li>Regulatory: Not approved for direct clinical use; industrial grade only.</li>
</ul>